Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

jefferies-maintains-buy-on-pstl,-raises-postal-realty-trust-pt-to-$24-feb-25-2026

Jefferies Maintains Buy on PSTL, Raises Postal Realty Trust PT to $24 Feb 25 2026

Feb 26, 2026

Jefferies on Feb 25, 2026 maintained a Buy on Postal Realty Trust, Inc. (PSTL) and raised its price…

Read more
evercore-isi-maintains-outperform-on-medline-inc-(mdln)-feb-25-2026

Evercore ISI Maintains Outperform on Medline Inc (MDLN) Feb 25 2026

Feb 26, 2026

The MDLN analyst rating update from Evercore ISI on February 25, 2026 kept an Outperform call and raised…

Read more
citigroup-maintains-neutral-on-atlanta-braves-holdings-(batrk)-feb-25,-2026

Citigroup Maintains Neutral on Atlanta Braves Holdings (BATRK) Feb 25, 2026

Feb 26, 2026

BATRK analyst rating: Citigroup maintained its Neutral rating on Atlanta Braves Holdings, Inc. (BATRK) on February 25, 2026.…

Read more
jefferies-maintains-buy,-raises-price-target-on-lowe’s-(low)-feb-25,-2026

Jefferies Maintains Buy, Raises Price Target on Lowe’s (LOW) Feb 25, 2026

Feb 25, 2026

Jefferies maintained a Buy rating on Lowe’s Companies, Inc. (LOW) and raised its price target to $305 from…

Read more
roth-maintains-lunr-(intuitive-machines,-inc.)-at-buy-on-feb-25,-2026

Roth Maintains LUNR (Intuitive Machines, Inc.) at Buy on Feb 25, 2026

Feb 25, 2026

Roth Capital maintained its Buy rating on LUNR (Intuitive Machines, Inc.) on Feb 25, 2026, citing stronger cash…

Read more
counterdrone-co-maintains-buy-rating-as-it-targets-au$2.3b-sales-pipeline-in-2026

Counterdrone Co. Maintains Buy Rating as it Targets AU$2.3B Sales Pipeline in 2026

Feb 25, 2026

DroneShield Ltd. (DRO:ASX; DRSHF:OTC) reported strong revenue growth and an inflection point for global C-UAS spending, according to…

Read more
crdf:-today’s-analyst-ratings-and-price-target-adjustment

CRDF: Today’s Analyst Ratings and Price Target Adjustment

Feb 25, 2026

Key Takeaways Piper Sandler maintains “Overweight” rating for Cardiff Oncology (CRDF) but lowers price target. New price target…

Read more

Treble Report: Nearly Half of Enterprise Buyers Now Start Vendor Research with AI, Ahead of Google Search

Feb 25, 2026

Treble, the preeminent earned media B2B technology public relations agency, today released its Press-to-Pipeline Activation in the Age…

Read more
jpmorgan-analyst-resumes-coverage-of-ovintiv-(ovv)-with-positive-outlook

JPMorgan Analyst Resumes Coverage of Ovintiv (OVV) with Positive Outlook

Feb 25, 2026

Key Takeaways: JPMorgan analyst Arun Jayaram has resumed coverage of Ovintiv (OVV) with an Overweight rating and a…

Read more
glj-research-maintains-sell-on-tesla,-inc.-(tsla)-feb-24,-2026

GLJ Research Maintains Sell on Tesla, Inc. (TSLA) Feb 24, 2026

Feb 25, 2026

GLJ Research maintained a Sell on Tesla, Inc. (TSLA) on February 24, 2026, the latest TSLA analyst rating.…

Read more
scotiabank-maintains-outperform-on-targa-resources-(trgp)-feb-24-2026

Scotiabank Maintains Outperform on Targa Resources (TRGP) Feb 24 2026

Feb 25, 2026

Scotiabank maintained an Outperform on Targa Resources Corp. on Feb 24, 2026, and raised the price target to…

Read more
hc-wainwright-maintains-buy-on-fulc-fulcrum-therapeutics,-inc.-feb-24,-2026

H.C. Wainwright Maintains Buy on FULC Fulcrum Therapeutics, Inc. Feb 24, 2026

Feb 25, 2026

H.C. Wainwright maintained a Buy rating on Fulcrum Therapeutics, Inc. (FULC) on February 24, 2026 after reviewing PIONEER…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 26
  6. 27
  7. 28
  8. 29
  9. 30
  10. 31
  11. 32
  12. ...
  13. 378
  14. »

Posts pagination

Newer posts Page 1 … Page 29 … Page 378 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.